New Delhi, Mar 31 (UNI) Sun Pharmaceutical Industries Ltd today said it has commercially launched generic Amifostine for Injection 500mg, which is therapeutically equivalent to Medlmmune's Ethyol.
The company's product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories, said a statement.
The firm had received a USFDA approval for this earlier in March 2008.
Ethyoi has annual sales of approximately 80 million dollars in the US.
Sun Pharma, being the first-to-file an ANDA for generic Ethyol, has a 180-day marketing exclusivity.
UNI PBB SR DS1145